These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31346643)

  • 1. [Doping in elite and popular sport : What orthopedic and trauma surgeons should know].
    Husen M; Jäger M
    Orthopade; 2019 Aug; 48(8):711-724. PubMed ID: 31346643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Bieri A; Kamber M; Sterchi M; Mullis PE
    Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation.
    Overbye M
    Int J Drug Policy; 2018 May; 55():14-30. PubMed ID: 29477956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sports physicians and the doping crisis in elite sport.
    Hoberman J
    Clin J Sport Med; 2002 Jul; 12(4):203-8. PubMed ID: 12131053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current anti-doping policy: a critical appraisal.
    Kayser B; Mauron A; Miah A
    BMC Med Ethics; 2007 Mar; 8():2. PubMed ID: 17394662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of doping use in high-level cycling: from team-organized doping to advances in the fight against doping.
    Lentillon-Kaestner V
    Scand J Med Sci Sports; 2013 Mar; 23(2):189-97. PubMed ID: 22092601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
    Anawalt BD
    Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National doping prevention guidelines: Intent, efficacy and lessons learned - A 4-year evaluation.
    Wippert PM; Fließer M
    Subst Abuse Treat Prev Policy; 2016 Oct; 11(1):35. PubMed ID: 27724975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug testing in elite athletes--the Israeli perspective.
    Epstein S; Eliakim A
    Isr Med Assoc J; 1999 Oct; 1(2):79-82. PubMed ID: 10731300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.
    Gleaves J; Petróczi A; Folkerts D; de Hon O; Macedo E; Saugy M; Cruyff M
    Sports Med; 2021 Sep; 51(9):1909-1934. PubMed ID: 33900578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medicolegal aspects of doping in sports].
    Pruvost J; Depiesse F
    Ann Readapt Med Phys; 2004 Aug; 47(6):263-73. PubMed ID: 15297116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new front in the war on doping: Amateur athletes.
    Henning AD; Dimeo P
    Int J Drug Policy; 2018 Jan; 51():128-136. PubMed ID: 28619395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Condemning and condoning: Elite amateur cyclists' perspectives on drug use and professional cycling.
    Outram SM; Stewart B
    Int J Drug Policy; 2015 Jul; 26(7):682-7. PubMed ID: 25666447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of doping use in elite sports: a review of numbers and methods.
    de Hon O; Kuipers H; van Bottenburg M
    Sports Med; 2015 Jan; 45(1):57-69. PubMed ID: 25169441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal hematologic profiles in elite cross-country skiers: blood doping or?
    Stray-Gundersen J; Videman T; Penttilä I; Lereim I
    Clin J Sport Med; 2003 May; 13(3):132-7. PubMed ID: 12792206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.